Georges H, Leroy O, Alfandari S, Guery B, Roussel-Delvallez M, Dhennain C, Beaucaire G
Service Universitaire de Réanimation Médicale et Maladies Infectieuses, Hôpital Chatilliez, Tourcoing, France.
Eur J Clin Microbiol Infect Dis. 1997 May;16(5):385-8. doi: 10.1007/BF01726369.
Vancomycin penetration in epithelium lining fluid was studied in ten mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia 24 hours after the onset of treatment. Vancomycin was given intravenously at a daily dose of 30 mg/kg. Vancomycin levels were detectable in four patients (range, 1-2.77 micrograms/ml). Concordance between high plasma concentrations (> 20 micrograms/ml) and detectable vancomycin levels in epithelium lining fluid was noted. These results suggest that the pulmonary disposition of vancomycin remains low for most patients 24 h after the onset of treatment compared with the minimum inhibitory concentrations for most gram-positive organisms. One therapeutic goal of vancomycin treatment could be to obtain through plasma levels of 20 micrograms/ml. Further studies are required to determine the clinical relevance of these observations.
在10例耐甲氧西林金黄色葡萄球菌肺炎的机械通气患者治疗开始24小时后,研究了万古霉素在上皮衬液中的渗透情况。万古霉素静脉给药,每日剂量为30mg/kg。4例患者可检测到万古霉素水平(范围为1-2.77μg/ml)。注意到高血浆浓度(>20μg/ml)与上皮衬液中可检测到的万古霉素水平之间存在一致性。这些结果表明,与大多数革兰氏阳性菌的最低抑菌浓度相比,在治疗开始24小时后,大多数患者万古霉素的肺部分布仍然较低。万古霉素治疗的一个治疗目标可能是通过血浆水平达到20μg/ml。需要进一步研究以确定这些观察结果的临床相关性。